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Bias in a protocol for a meta-analysis of 5-HTTLPR,
stress, and depression
Terrie E Moffitt1* and Avshalom Caspi2
Bias in a protocol for a meta-analysis of 5-HTTLPR,
stress, and depression
We are delighted to see pre-study publication in BMC
Psychiatry [1] of the research design and plans for meta-
analysis of the literature on the interaction between
serotonin transporter genotype and life stress, predicting
depression [2]. However, we recommend two changes:
dropping “Primary Analysis Plan 2” and including stud-
ies in the meta-analysis with sample sizes under 300
participants. In mid-2012 we wrote to the group of re-
searchers involved in the meta-analysis, expressing these
two concerns with the plan. Because these concerns
have not been adequately addressed in the published
protocol, we submit this correspondence.
Issue 1: “Primary Analysis Plan 2” to study lifetime
depression does not allow for establishing temporal
order between stress and depression
Primary Analysis Plan 2 in Culverhouse et al. [1] states
that studies that measured stress and depression using
lifetime measurement will be included in the meta-
analysis. However, these studies should not be used in
the forthcoming meta-analysis because using lifetime
measures precludes establishing temporal order between
a hypothesized cause and a hypothesized effect. The hy-
pothesis in question is that individuals with an at-risk
serotonin transporter genotype are likely to develop de-
pression after life stress and in response to it. The min-
imal criterion for a valid test of this hypothesis is a set of
measures that can unambiguously establish that the
stress came before the depression. When using lifetime
measures one cannot simply make the assumption that
stress came before the depression, because there is a lit-
erature showing that individuals with depression tend to
experience more stressful life events as a consequence of
their mood disorder [3]. This well-known phenomenon
is referred to in the literature as “stress generation” [4].
For example, depressed individuals have elevated rates of
intimate partner violence and divorce. To use retro-
spective reports of lifetime depression in a test of this
GxE hypothesis is tantamount to using lifetime weight to
test hypotheses about the cause of low birth-weight, or to
use lifetime IQ to test hypotheses about causes of IQ de-
cline in Alzheimer’s dementia; the measure sounds the
same, but it is not. Timing is everything. The importance
of temporal order in hypothesis testing in studies having
observational designs is nicely explained in a powerpoint
lecture "What Do Survey Data Really Mean? Considering
Issues of Causality and Temporality in Survey Research,"
by Seth Noar (http://www.nidcr.nih.gov/Research/DER/
BSSRB/PowerPointPresentations/default.htm). Strong GxE
tests documenting that stress antedated depression exist,
but are not included in the meta-analysis (e.g., [5]).
Setting aside for the moment the question of temporal
order between cause and effect, studies using lifetime
measures should not be used because these measures
are inaccurate, inadequate, and misleading as measures
of depression and stress. The literature contains ample
documentation that retrospective recall of lifetime de-
pression is inadequate for research purposes. We reviewed
this evidence in Psychological Medicine [6], and since then
the inadequacy of retrospective recall of lifetime depres-
sion has been demonstrated in multiple studies [7–9]. To-
gether these and prior papers show that retrospective
lifetime reports overlook at least half of depression cases.
Thus Plan 2 of the meta-analysis will wrongly assign many
individuals who have had depression to the non-depressed
outcome group. Numerous publications have noted that
retrospective checklists of lifetime stressful life events are
likewise unsuitable for research purposes [10,11]. In rela-
tion to the subject of the proposed meta-analysis, GxE re-
search, the poor accuracy of these retrospective recall
measures is particularly important. Simulation studies
reveal that the difference between measurements that
are unreliable (correlation with true score = 0.4) vs reliable
(0.7) corresponds to a large difference in sample size. Thus,
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although measuring environmental exposure is costly,
doing it well can pay for itself by reducing sample size
[12]. However, our concern is that lifetime measures of
stress and depression in the forthcoming meta-analysis
are not merely unreliable, they are also invalid, and there-
fore they contaminate the meta-analysis with misinfor-
mation. Increased power afforded by larger N sometimes
counterveils unreliable measurement, but large N cannot
counterveil invalid data. Unfortunately, the biasing influ-
ence of invalid data in a meta-analysis is exacerbated by
large samples.
The BMC Psychiatry methods paper includes two
plans. It includes Primary Analysis 1, a new separate
plan to study only those data sets that can establish tem-
poral order between stress and depression. We applaud
the addition of Plan 1. The paper also retains Primary
Analysis 2, the original plan to study lifetime depression
including all studies available, which we argued above
is inappropriate. We must query why Plan 2 is still
retained. The abovementioned flaws in Plan 2 should
come as no surprise, because our point about the im-
portance of accurate measurement of temporal order is
not new. We addressed it empirically in our original
Science paper reporting the GxE in question [2]. In
that paper we estimated the GxE effect using a measure
of life events that occurred prior to depression and we es-
timated it again using a measure of life events that oc-
curred after depression. Results showed empirically that
unless the stress occurred before the depression, the GxE
finding was not observed. Culverhouse et al. carefully
and rightly emphasize the importance of matching the
design features of a replication analysis as closely as pos-
sible to design features of the original publication. How-
ever, Plan 2 not only fails to match the design of the
original publication, it includes a design feature that the
original publication tested and advised against.
We suspect that Plan 2 is retained solely because it of-
fers an attention-getting large sample size. To quote
Culverhouse et al. [1], “Our second set of primary ana-
lyses will involve larger sample sizes, including children
and adults of all ages. The increase in sample size will
result in increased power if there is a broad genetic
association between 5-HTTLPR genotypes, stress, and
depression. However, this comes at a cost; in these ana-
lyses, we give up the opportunity to investigate whether
stress preceding depression was a potential cause of the
depression, as relative timing of stress and depression
may not be known, and thus will not be included in the
models.” We anticipate that even if the more focused
Analysis 1 (closer design replication, smaller N) shows
evidence of the interaction, the results of Plan 2 (which is
not a replication, but has a larger N) will be those most
likely to be highlighted by the authors, covered in the
media, and remembered by the public. Plan 2’s result will
be rendered more salient to readers because of its an-
ticipated sample size exceeding 30,000 participants.
This appears to be the rationale for retaining this plan,
despite the fact that its design was shown to be flawed by
Caspi et al. [2]).
Issue 2: The protocol excludes studies with N < 300
The protocol excludes many important studies, in part
because of their design features (e.g., case-only designs;
[13]) or because they reported symptom dimensions ra-
ther than categorical diagnoses of depression (e.g., [14]).
However, here we focus on sample size as this has been
pivotal in the debate. Discovery science in genetics re-
quires large samples, but hypothesis-testing science does
not necessarily. The Culverhouse et al. replication pro-
ject is not discovery science, it is hypothesis-testing sci-
ence. In hypothesis-testing science, the consideration of
sample size is secondary to more primary considerations
of quality of the measures and correctness of design.
This order of priorities may be particularly true of hy-
pothesis testing using a meta-analysis approach, as
the approach itself provides more than ample sample
size. Many of the best-designed studies for testing
the GxE hypothesis in question have samples under
300; these smaller studies are significantly more likely to
be prospective-longitudinal and to utilize face-to-face in-
terviews [15]. These smaller studies are also more likely
to be able to establish temporal order between cause
(stress) and effect (depression). In particular, studies of
medical illness stressors overcome the problems of vari-
able stressors between subjects and inaccurate retro-
spective assessment that compromise power in many
other GxE studies. However these medical-stressor stud-
ies are typically small, and as a result the protocol plan
has excluded them. Some studies the protocol includes,
no matter how large, must be designated unsuitable for
this project if their measures of stress and depression are
weak on validity, as is common when data must be col-
lected through the post, telephone, or internet to contain
costs of assessing a large sample. When it comes to
measuring stress and depression, face-to-face clinical in-
terviews have superior reliability and validity but are
more expensive, usually necessitating smaller samples.
Again, Culverhouse et al. have emphasized the import-
ance of matching features of a replication analysis as
closely as possible to features of the original published
study. The original published study used face-to-face
clinical interviews. Thus, the protocol plans to include
studies that fail to match the design of the original pub-
lication in the key area of measurement, and most such
studies have very large Ns. Moreover, as noted above,
large-N studies are even more unsuitable if their de-
signs do not allow establishing clear temporal order be-
tween hypothetical cause and outcome. The protocol’s
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over-emphasis on sample size of individual studies, coupled
with exclusion of many well-designed studies for testing
the hypothesis, is misguided.
The rationale given in the Culverhouse et al. protocol
for exclusion of small studies is that more small studies
have claimed positive findings. They note small-N stud-
ies run a risk of publication bias. Such bias emerges
when a small-N study with a negative finding is more
often “file-drawered” because it is not deemed rigorous
enough to constitute decisive rejection of the null,
whereas a small-N study with a positive finding would
be more often published because it was able to reject the
null despite being under-powered. However, the simple
fact that more small studies have obtained positive find-
ings does not by itself constitute evidence of such pub-
lication bias, particularly when there are systematic
differences in quality between small studies and large
studies. Moreover, it has been commented before that in
relation to this particular GxE finding, both researchers
and editors have been quite keen to publish negative
findings (6 nagative reports have appeared in the last
3 years, all of which are taking part in the meta-analysis,
although curiously most positive reports appearing over
this time period have not been invited to take part). Cul-
verhouse et al. allow unpublished studies to submit data
for the meta-analysis, and they report that they have
trawled for these unpublished studies. As such, requiring
N > 300 to prevent the file drawer problem does not seem
necessary.
Our point about sample size is not new. We explained
it in our American Journal of Psychiatry paper [16], Uher
et al. explained it in two publications [15,17], and Karg
et al. also explained it in their meta-analysis [18]. Yet, the
meta-analysis protocol does not contain a justification of
its choice of N = 300 as a cut off for study inclusion. Why
not 500, why not 200? According to PRISMA guidelines
for reporting meta-analyses, those that aspire to be au-
thoritative provide a rationale for their decision points, e.g.,
“Specify study characteristics used as criteria for eligibility,
giving rationale” (http://www.prisma-statement.org/2.1.2%
20-%20PRISMA%202009%20Checklist.pdf).
Culverhouse et al. include an a priori plan to test for
effects of study design features on heterogeneity in find-
ings, and include a list of five design features to be
tested. We applaud this approach. However, the list of
design features to be tested omits sample size. We find
this omission curious because sample size has been at
the heart of debate in the literature about prior meta-
anlayses of this GxE. The heterogeneity analyses pro-
posed by Culverhouse (cross-sectional vs. longitudinal,
interview vs. questionnaire, specific stressor vs. undiffer-
entiated stressor) are important analyses to guide the field
going forward. Unfortunately, because so many high-
quality longitudinal, interview-based, and specific-stressor
studies have been excluded by the sample-size restriction,
the results of the planned analyses will be difficult to inter-
pret. Excluding small studies instead of testing for their pu-
tative bias on findings seems a missed opportunity for the
Culverhouse team. In fact, our claim is not really that
smaller studies are more desirable. Our claim is that the
largest studies are least desirable because they have the
worst measurement technology and in many cases have
been unable to establish temporal order, which is rather
different. Including a test of sample size as a heterogeneity
factor could shed light on the veracity of our claim.
These two issues that we raise here, temporal order
and sample size, are not new to observational hypothesis-
testing research. They apply to all observational studies,
beyond the special case of GxE studies. Other meta-
analyses of this GxE hypothesis have made these same
methodological mistakes before, and these mistakes have
been repeatedly pointed out in published articles in the
past five years. As such, the protocol as published seems
fundamentally and inexplicably flawed. As we said in our
2012 letter to the meta-analysis collaborators, we regret
this missed opportunity to do something better.
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